ganitumab

English

Etymology

-tu- (“tumor”) +‎ -umab (“human monoclonal antibody”).

(This etymology is missing or incomplete. Please add to it, or discuss it at the Etymology scriptorium.)

Noun

ganitumab (uncountable)

1. (pharmacology) A human monoclonal antibody against type 1 insulin-like growth factor receptor, designed for the treatment of cancers.
   • 2015 July 15, “IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas”, in PLOS ONE‎^[1], →DOI:

     While a randomized Phase II study testing the addition of the IGF1R mab ganitumab to chemotherapy in EWS is ongoing (NCT02306161), CAR T cells targeting IGF1R may be an alternative treatment for high risk patients with EWS and other sarcomas.